ExodusPoint Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,843
| Closed | -$2.49M | – | 2003 |
|
|
2025
Q1 | $2.49M | Buy |
18,843
+4,604
| +32% | +$607K | 0.02% | 580 |
|
|
2024
Q4 | $1.19M | Buy |
+14,239
| New | +$1.19M | 0.01% | 819 |
|
|
2024
Q1 | – | Sell |
-11,895
| Closed | -$852K | – | 1931 |
|
|
2023
Q4 | $852K | Sell |
11,895
-16,765
| -58% | -$1.2M | 0.01% | 802 |
|
|
2023
Q3 | $1.49M | Sell |
28,660
-11,298
| -28% | -$589K | 0.01% | 760 |
|
|
2023
Q2 | $2.53M | Buy |
+39,958
| New | +$2.53M | 0.02% | 634 |
|
|
2021
Q4 | – | Sell |
-6,859
| Closed | -$256K | – | 2621 |
|
|
2021
Q3 | $256K | Buy |
+6,859
| New | +$256K | ﹤0.01% | 1633 |
|
|
2020
Q4 | – | Sell |
-84,027
| Closed | -$2.16M | – | 2375 |
|
|
2020
Q3 | $2.16M | Buy |
+84,027
| New | +$2.16M | 0.04% | 338 |
|
|
2020
Q1 | – | Sell |
-16,490
| Closed | -$566K | – | 1673 |
|
|
2019
Q4 | $566K | Buy |
16,490
+4,108
| +33% | +$141K | 0.01% | 740 |
|
|
2019
Q3 | $92K | Buy |
12,382
+1,857
| +18% | +$13.8K | ﹤0.01% | 1214 |
|
|
2019
Q2 | $137K | Buy |
+10,525
| New | +$137K | 0.01% | 962 |
|